How NHS collaboration with the pharma industry could benefit both players

A meeting underway with hands pointing at graph data

The challenge to find cost-savings while innovating services presents issues for both the NHS and the pharmaceutical industry to address, but an opportunity to collaborate could bring them closer together for the benefit of all. PA Consulting Group colleagues Dr Stephen Black and Ian Rhodes explain.

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here